|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0026565,
umls-concept:C0205195,
umls-concept:C0205217,
umls-concept:C0237401,
umls-concept:C0243009,
umls-concept:C0301625,
umls-concept:C0332281,
umls-concept:C0439234,
umls-concept:C0521026,
umls-concept:C1300557,
umls-concept:C1704686,
umls-concept:C1963724
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-11-19
|
|
pubmed:abstractText |
To determine the long-term impact of immunologic discordance (viral load <50 copies/mL and CD4+ count <=200 cells/mm3) in antiretroviral-naive patients initiating combination antiretroviral therapy (cART).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1944-7884
|
|
pubmed:author |
pubmed-author:AntoniouTonyT,
pubmed-author:BayoumiAhmedA,
pubmed-author:CANOC Collaboration,
pubmed-author:ChanKeithK,
pubmed-author:CooperCurtisC,
pubmed-author:GenebatMiguelM,
pubmed-author:HoggRobert SRS,
pubmed-author:KleinMarina BMB,
pubmed-author:LoutfyMona RMR,
pubmed-author:MachoufNimaN,
pubmed-author:MilanDavidD,
pubmed-author:MillsEdwardE,
pubmed-author:MontanerJulio S GJS,
pubmed-author:MooreDavidD,
pubmed-author:RaboudJanetJ,
pubmed-author:RachlisAnitaA,
pubmed-author:RourkeSean BSB,
pubmed-author:ShenAnyaA,
pubmed-author:SmiejaMarekM,
pubmed-author:TsoukasChrisC,
pubmed-author:WalmsleySharon LSL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
451-9
|
|
pubmed:dateRevised |
2011-9-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21105259-Adult,
pubmed-meshheading:21105259-Anti-Retroviral Agents,
pubmed-meshheading:21105259-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:21105259-CD4 Lymphocyte Count,
pubmed-meshheading:21105259-Critical Illness,
pubmed-meshheading:21105259-Female,
pubmed-meshheading:21105259-HIV Infections,
pubmed-meshheading:21105259-HIV-1,
pubmed-meshheading:21105259-Humans,
pubmed-meshheading:21105259-Male,
pubmed-meshheading:21105259-Middle Aged,
pubmed-meshheading:21105259-Risk Factors,
pubmed-meshheading:21105259-Treatment Outcome,
pubmed-meshheading:21105259-Viral Load
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
|
|
pubmed:affiliation |
University of Toronto, Toronto, Ontario, Canada. mona.loutfy@wchospital.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
